Chris Ho

Chris Ho is an accomplished professional with extensive experience in the field of drug discovery and computational chemistry. As a Senior Research Fellow at Qubit Pharmaceuticals since July 2020, Chris utilizes advanced software and machine learning technologies to enhance drug development processes. In 1996, Chris founded Drug Design Methodologies, serving as Owner and Chief Scientific Officer, focusing on addressing challenges in computational biology and drug design through corporate collaborations. With a background in developing a multi-omics platform with Washington University, Chris has also founded Mostly There, an augmented and mixed reality studio, and previously served as a Senior Research Scientist at Washington University in St. Louis's School of Medicine. Chris's early career includes independent consulting in computer-aided ligand design and a robust education, holding both M.D. and Ph.D. degrees in Medicine and Pharmacology from Washington University and a Bachelor of Science in Biology from Purdue University.